Patent sales conducted in 2025 are not anticipated to be a regular part of the company's revenue narrative, as management ...

Human-made glass is thousands of years old. But it’s now poised to find its way into the AI chips used in the world’s newest ...

Q4 2025 Earnings Call March 12, 2026 4:30 PM EDTCompany ParticipantsEdward McGregor - Director of Investor RelationsPaul Travers ...

Full-Year Revenue -- $6.3 million, a 9% increase, driven by 4% growth in product sales and a 27% increase in engineering ...

Additionally, I'd like to walk you through the structural changes underway at Ballard and the foundations we are laying in building towards sustained positive cash flow over the next 2 years. Let me ...

DEVCOM Army Research Laboratory was named 2025 Science and Technology Reinvention Laboratory of the Year by the Army Acquisition Executive.

Eupraxia Pharmaceuticals Inc. ('Eupraxia” or the 'Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize ...

Vivid Seats Inc. (NASDAQ: SEAT) (“Vivid Seats” or “we”), a leading marketplace that utilizes its technology platform to connect millions of buyers with thousands of ticket sellers across hundreds of ...

Bill Cooper stated, "We expect a sequential decline in non-product revenue due to a project completion in Q4 2025, which will ...

Procedure Revenue -- $31.8 million, reflecting a 13% decline primarily linked to higher clinic attrition and lower procedure volumes. Dietary Supplement Revenue -- Grew 16% to $11.7 million, driven ...

Central 1 Credit Union (Central 1) today reported fourth quarter and year-end 2025 performance ahead of expectations.

Quantum Computing Inc. ("QCi" or the "Company") (Nasdaq: QUBT), an innovative, quantum optics and integrated photonics technology company, today released financial results for the three and ...